X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5979) 5979
Publication (440) 440
Book Review (14) 14
Book Chapter (10) 10
Conference Proceeding (9) 9
Dissertation (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5560) 5560
female (3495) 3495
middle aged (2029) 2029
male (1948) 1948
index medicus (1819) 1819
aged (1631) 1631
adult (1604) 1604
mucin-1 - metabolism (1556) 1556
immunohistochemistry (1513) 1513
mucin-1 (1459) 1459
oncology (1317) 1317
animals (1164) 1164
mucin-1 - analysis (1010) 1010
pathology (1000) 1000
mucin-1 - genetics (915) 915
expression (889) 889
muc1 (846) 846
cancer (829) 829
mucin-1 - blood (828) 828
mice (785) 785
mucins (785) 785
mucin-1 - immunology (767) 767
aged, 80 and over (667) 667
prognosis (651) 651
breast cancer (624) 624
breast neoplasms - pathology (605) 605
keratins - analysis (553) 553
biomarkers, tumor - analysis (549) 549
tumors (542) 542
diagnosis, differential (531) 531
carcinoma (522) 522
cell line, tumor (514) 514
biomarkers, tumor - blood (475) 475
membrane glycoproteins - analysis (469) 469
breast-cancer (454) 454
molecular sequence data (432) 432
biochemistry & molecular biology (428) 428
immunoenzyme techniques (414) 414
cell biology (408) 408
diagnosis (395) 395
immunology (393) 393
mucin-1 - chemistry (388) 388
amino acid sequence (375) 375
glycosylation (363) 363
mucin (360) 360
breast neoplasms - blood (357) 357
sensitivity and specificity (354) 354
antigens, neoplasm - analysis (353) 353
antigen (352) 352
monoclonal-antibodies (349) 349
carcinoembryonic antigen - analysis (348) 348
antigens (332) 332
research (324) 324
retrospective studies (322) 322
cells (321) 321
mucin-1 - biosynthesis (314) 314
analysis (311) 311
neoplasms (309) 309
breast neoplasms - immunology (308) 308
immunotherapy (306) 306
adolescent (303) 303
metastasis (303) 303
surgery (294) 294
neoplasm staging (293) 293
biomarkers, tumor - metabolism (289) 289
breast neoplasms - metabolism (288) 288
carcinoembryonic antigen - blood (283) 283
vimentin - analysis (283) 283
tumor cells, cultured (282) 282
proteins (274) 274
protein (267) 267
antibodies, monoclonal (266) 266
gene expression (263) 263
breast neoplasms - diagnosis (260) 260
adenocarcinoma (251) 251
follow-up studies (251) 251
carcinoembryonic antigen (250) 250
adenocarcinoma - pathology (243) 243
medicine & public health (242) 242
medicine, research & experimental (242) 242
polymorphic epithelial mucin (241) 241
s100 proteins - analysis (234) 234
article (229) 229
antibodies (228) 228
enzyme-linked immunosorbent assay (226) 226
antigens, neoplasm (224) 224
biomarkers - blood (224) 224
digestive system diseases (224) 224
keratins - metabolism (221) 221
care and treatment (220) 220
mucins - metabolism (220) 220
gene expression regulation, neoplastic (217) 217
research article (213) 213
skin and connective tissue diseases (210) 210
cea (207) 207
biomarkers (204) 204
treatment outcome (202) 202
antibodies, monoclonal - immunology (201) 201
predictive value of tests (200) 200
lymphatic metastasis (199) 199
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5531) 5531
Chinese (171) 171
Japanese (106) 106
French (62) 62
German (30) 30
Spanish (22) 22
Polish (21) 21
Russian (18) 18
Italian (11) 11
Czech (3) 3
Romanian (3) 3
Bosnian (1) 1
Bulgarian (1) 1
Greek (1) 1
Hungarian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1125 - 1133
Summary Background Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on... 
Hematology, Oncology and Palliative Medicine | DOUBLE-BLIND | PROGNOSTIC-FACTORS | GENE | ONCOLOGY | EXPRESSION | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vaccinia virus - genetics | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Cancer Vaccines - therapeutic use | Interleukin-2 - immunology | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Carcinoma, Non-Small-Cell Lung - pathology | Risk Assessment | Deoxycytidine - administration & dosage | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Cancer Vaccines - adverse effects | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - immunology | Disease-Free Survival | Interleukin-2 - genetics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Membrane Glycoproteins - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucin-1 - immunology | Vaccines, Synthetic | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Membrane Glycoproteins - adverse effects | Deoxycytidine - analogs & derivatives | Mucin-1 - genetics | Index Medicus | Interleukin-2 | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Life Sciences | Cancer Vaccines | Membrane Glycoproteins | Antineoplastic Combined Chemotherapy Protocols | Cisplatin | Mucin-1 | Vaccinia virus | Deoxycytidine | Antimetabolites, Antineoplastic | Cancer
Journal Article
Laboratory Investigation, ISSN 0023-6837, 09/2017, Volume 97, Issue 9, pp. 1103 - 1113
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 07/2011, Volume 10, Issue 7, pp. 3040 - 3049
Proteomic analysis of samples isolated by laser capture microdissection from clinical specimens requires sample preparation and fractionation methods suitable... 
high resolution mass spectrometry | QUANTITATIVE PROTEOMICS | INCREASED EXPRESSION | SHOTGUN PROTEOMICS | N-GLYCOPROTEOME | colon cancer | SAMPLE PREPARATION | BIOCHEMICAL RESEARCH METHODS | CELL-GROWTH | laser capture microdissection | MASS-SPECTROMETRY | HUMAN COLORECTAL-CANCER | MITOTIC CHECKPOINT GENES | FFPE | FASP | MEMBRANE-PROTEINS | Mucin-2 - genetics | Colonic Neoplasms - genetics | Peptide Fragments | Proteome - genetics | Carcinoembryonic Antigen - chemistry | Transcription Factors - chemistry | Microdissection | Formaldehyde - chemistry | Cell Count | Humans | Gene Expression Regulation, Neoplastic | CD55 Antigens - genetics | Carcinoembryonic Antigen - genetics | Dextrans - chemistry | Polyethylene Glycols - chemistry | CD55 Antigens - chemistry | Proteome - chemistry | Mucin-2 - chemistry | Paraffin Embedding | Tandem Mass Spectrometry | Lasers | Mucin-1 - analysis | Mucin-1 - chemistry | Chromatography, Liquid | Colonic Neoplasms - chemistry | Proteomics - methods | CD55 Antigens - analysis | Biomarkers, Tumor - analysis | Mucin-2 - analysis | Fixatives - chemistry | Proteome - analysis | Transcription Factors - genetics | Carcinoembryonic Antigen - analysis | High-Throughput Screening Assays | Cell Line, Tumor | Biomarkers, Tumor - genetics | Transcription Factors - analysis | Biomarkers, Tumor - chemistry | Mucin-1 - genetics
Journal Article
Cancer Research, ISSN 0008-5472, 06/2009, Volume 69, Issue 12, pp. 5133 - 5141
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0145920
It remains challenging to produce decisive vaccines against MUC1, a tumor-associated antigen widely expressed by pancreas, breast and other tumors. Employing... 
CELL LUNG-CANCER | BREAST-CANCER | DENDRITIC CELLS | POLYMORPHIC EPITHELIAL MUCIN | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | IN-VIVO | ERADICATE TUMORS | T-CELLS | SELF-TOLERANCE | ANTIGEN | Mucin-1 - metabolism | Tumor Escape | Peptides - chemistry | Humans | Peptides - immunology | Neoplasms, Experimental - prevention & control | Mice, Transgenic | Glycosylation | Cancer Vaccines - chemistry | Antigens - chemistry | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Animals | Antigens - therapeutic use | T-Lymphocytes - metabolism | Neoplasms, Experimental - immunology | Mucin-1 - immunology | Cell Line, Tumor | Antigens - immunology | T-Lymphocytes - immunology | Mice | Peptides - therapeutic use | Mucin-1 - genetics | Cancer vaccines | Prevention | Physiological aspects | Genetic aspects | Research | Pancreatic cancer | Cell culture | Animal models | Peptides | CD8 antigen | Lung cancer | Vaccination | Oncology | Biochemistry | Lymphocytes T | Vaccines | Cancer therapies | Skin cancer | Immunology | Transgenic animals | Immunotherapy | Synthetic peptides | Pancreas | Carbohydrates | Medical research | Antigens | Hematology | Dendritic cells | Transgenic mice | Melanoma | Breast cancer | Immunological tolerance | CD4 antigen | Chemotherapy | Major histocompatibility complex | Antigen (tumor-associated) | Avidity | Interferon | Aberration | Tumors
Journal Article
Immunity, ISSN 1074-7613, 06/2016, Volume 44, Issue 6, pp. 1444 - 1454
Journal Article